Calian Group (TSE:CGY – Get Free Report) had its price target increased by stock analysts at Ventum Financial from C$62.00 to C$72.00 in a note issued to investors on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Ventum Financial’s price target would suggest a potential upside of 13.12% from the company’s previous close.
Other research analysts also recently issued research reports about the stock. CIBC boosted their target price on shares of Calian Group from C$62.00 to C$65.00 in a research note on Wednesday, January 14th. Royal Bank Of Canada upped their price objective on shares of Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a research note on Thursday, November 27th. Canaccord Genuity Group lifted their target price on shares of Calian Group from C$60.00 to C$63.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Finally, Desjardins increased their price target on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Five research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Calian Group presently has a consensus rating of “Buy” and an average price target of C$66.40.
Check Out Our Latest Stock Analysis on CGY
Calian Group Stock Down 1.1%
Calian Group (TSE:CGY – Get Free Report) last posted its earnings results on Wednesday, November 26th. The company reported C$1.00 earnings per share (EPS) for the quarter. The firm had revenue of C$203.18 million for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. Equities analysts expect that Calian Group will post 4.9475219 earnings per share for the current fiscal year.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Recommended Stories
- Five stocks we like better than Calian Group
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
